Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other parts of the body. It is estimated that about 1% of the global population suffers from RA, and it is more common in women than men.

CRP is now enrolling participating in a clinical trial that is evaluating the effectiveness and safety of a new class of RA treatments that are not yet available on the market.

Get started now

  • Diagnosed with adult-onset Rheumatoid Arthritis (RA) with moderate to severe tenderness in the joints

  • Over 18 years of age

  • Still experience symptoms after being on at least one Disease-modifying antirheumatic drugs (DMARDs)

  • Patients must have health insurance coverage (both medical and prescription drug coverage)

Who is it for?

  • Study-related medication

  • Exams & lab work at no cost

  • If you qualify, you may be compensated for time and travel

Benefits for participants











Don’t see what you’re looking for?